This dividend ETF's focus beyond yield continues to pay off for investors.

Merck (MRK) concluded the recent trading session at $126.78, signifying a -2.15% move from its prior day's close.

The YieldMax MSTR Option Income Strategy ETF (NYSEARCA:MSTY) is the single-stock income product retail investors flocked to when MicroStrategy (now Strategy) was climbing alongside Bitcoin.

On July 02, 2026, Merck and Co Inc (MRK) shares rose 3.3% today, currently priced at $129.56. The stock has experienced significant price appreciation, trading wi

Merck stock is in a buy zone after hitting a new high. Fellow Dow stock JPMorgan Chase and Amphenol are both trading around entry points.

Portfolio concentration and sector weightings set these two popular income funds apart for investors seeking steady cash flow.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4.

A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck and AbbVie, were involved in clinical trials conducted in China that may have supported the country's military capabilities, according to a Reuters report. The inquiry, led by Republican Representative John Moolenaar of Michigan, chair of the House Select Committee on China, focuses on whether the drugmakers conducted adequate due diligence and maintained sufficient data protection standards at trial sites in China.

Stock futures are pointed lower to end the month and quarter as AI capex concerns linger

A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck...